Business
Why the Neuren (ASX:NEU) share price is moving higher today
Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trending higher in early afternoon trade. This comes after the biotech company announced it has successfully completed manufacturing a drug substance for its Phase 2 trials.
At the time of writing, the Neuren share price has jumped to an intraday high of $1.28, up 1.99% for the day so far.
What did Neuren announce?
The Neuren share price is edging higher as investors appear pleased with the company’s progress.
According to its release, Neuren’s second drug candidate, NNZ-2591, has been manufactured ahead of Phase 2 trials. The company is currently preparing to submit Investigational New Drug…
-
Noosa News24 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News16 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
General20 hours agoWallaroos fall to Black Ferns 37-12 in Wellington Test
-
General18 hours agoCalifornia worker dead and hundreds arrested after cannabis farm raid